Guerriero G, Liljedahl SI, Carlsen HK, López Muñoz M, Daros AR, Ruocco AC, Steingrimsson S. Transcutaneous auricular vagus nerve stimulation to acutely reduce emotional vulnerability and improve emotional regulation in borderline personality disorder (tVNS-BPD): study protocol for a randomized, single-blind, sham-controlled trial. Trials. 2024 Jun 19;25(1):397. doi: 10.1186/s13063-024-08230-6. PMID: 38898522; PMCID: PMC11186228.
Guerriero G, Wartenberg C, Bernhardsson S, Gunnarsson S, Ioannou M, Liljedahl SI, et al. Efficacy of transcutaneous vagus nerve stimulation as treatment for depression: A systematic review. Journal of Affective Disorders Reports. 2021;6:100233.
Perna G, Guerriero G, Brambilla P, Caldirola D. Panic and the brainstem: clues from neuroimaging studies. CNS Neurol Disord Drug Targets. 2014;13(6):1049–56.
Grassi M, Caldirola D, Vanni G, Guerriero G, Piccinni M, Valchera A, et al. Baseline respiratory parameters in panic disorder: a meta-analysis. Journal of Affective Disorders. 2013 Apr;146(2):158–73.
Perna G, Guerriero G, Caldirola D. Emerging drugs for panic disorder. Expert opinion on emerging drugs. 2011 Dicembre;16(4):631–45
Other Journals
Riva A, Cavedini P, Guerriero G, Prestia D, Grassi M, Perna G. 2169 – Does nicotine have a procognitive effect in obsessive-compulsive disorder? European Psychiatry. 2013 Jan 1;28:1.
Grassi M, Caldirola D, Guerriero G, Prestia D, Dal Santo B, Perna G. 2174 – Comparison of baseline respiratory parameters between panic disorder and other anxiety disorders: A meta-analysis. European Psychiatry. 2013 Jan;28:1.
Perna G, Guerriero G, Menotti R, Caldirola D. Dimensioni psicopatologiche e non adesione alle cure nel disturbo di panico. J Psychopat. 2012;18:S97.
Guerriero G, Perna G, Camardese G, Janiri L, Pozzi G, Restuccia D. High Frequency Oscillations (HFOs) nel Disturbo di Panico: gating sensoriale e coinvolgimento colinergico. J Psychopat. 2012;18:S206-7.
Frustaci A, Codardo M, Guerriero G, Janiri L, Pozzi G. P0089 - External validation of the axis V of Kennedy by symptom rating scales in patients with anxiety disorders. European Psychiatry. 2008 Apr; 23(S2):S218–S218.
Bosia M, Cavallaro R, Benedetti F, Guerriero G, Cocchi F, Marino E, et al. P.3.10 Association study of GSK-3β \textminus50T/C polymorphism with haloperidol resistance in schizophrenia. European Neuropsychopharmacology. 2007 Mar;17:S77–8.
Posters
Guerriero G, Wartenberg C, Bernhardsson S, Gunnarsson S, Ioannou M, Liljedahl SI, Magnusson K, Svanberg T, Steingrimsson S. Transcutaneous vagus nerve stimulation applications in psychiatry. Kvalitets- och forsknignsdag område 2, Sahlgrenska Universitetssjukhus 2021, Gothenburg, Sweden
Guerriero G, Grandinetti P, Perna G, Schipani R, De Angelis A, Janiri L, Restuccia D, Pozzi G. High Frequency Oscillations modifications in panic disorder and generalized anxiety disorders. 11th Congress of the Italian Society of Biological Psychiatry (SIPB) 2013, Rome, Italy
Alciati A. Prestia D, Guerriero G, Motta A, Perna G. The association between childhood trauma and psychiatric psychopathology from an epigentic point of view. 11th Congress of the Italian Society of Biological Psychiatry (SIPB) 2013, Rome, Italy
Grassi M, Caldirola D, Guerriero G, Prestia D, Dal Santo B, Perna G. Comparison of Baseline Respiratory parameters between panic disorder and other anxiety disorders: a meta-analysis. 21st European congress of Psychiatry 2013, Nice, France
Riva A, Cavedini P, Guerriero G, Prestia D, Grassi M, Perna G. Does nicotine have a pro-cognitive effect in obsessive-compulsive disorder? 21st European congress of Psychiatry 2013, Nice, France
G. Guerriero, G. Perna, G. Camardese, L. Janiri, G. Pozzi, D. Restuccia. High Frequency Oscillations (HFOs) in Panic Disorder: sensory gating and cholinergic involvement. 16th Congress of the Italian Society of Psychopathology (SOPSI) 2012, Rome, Italy
Grandinetti P, Solaroli S, Guerriero G, Frustaci A, Janiri L, Pozzi G. Preliminary analysis of coping in a sample of outpatients with anxiety disorders. 15th Congress of the Italian Society of Psychopathology (SOPSI) 2011, Rome, Italy
Solaroli S, Guerriero G, Frustaci A, Grandinetti P, Gangemi A, Janiri L, Pozzi G. Correlates of subjective improvement in a cohort of outpatients being treated for anxiety disorders. 15th Congress of the Italian Society of Psychopathology (SOPSI) 2011, Rome, Italy
Frustaci A, Codardo M, Guerriero G, Janiri L, Pozzi G. External validation of the Axis V of Kennedy by symptom rating scales in patients with anxiety disorders. 16th European Congress of Psychiatry 2008, Nice, France
Bosia M, Cavallaro R, Benedetti F, Guerriero G, Cocchi F, Marino E, Smeraldi E. Association Study of Gsk-3beta –50 T/C polymorphism with Haloperidol resistance in schizophrenia. ENCP Workshop on Neuropsychopharmacology for Young Scientists in Europe 2007, Nice, France
Chapter in books
Guerriero G. I comportamenti autolesivi. In: Camerota TC, editor. Adolescenti e salute: Aiutiamo i nostri figli a crescere sani. Pratici consigli di medici e specialisti. FrancoAngeli; 2024. p. 79–87. Available from: https://www.francoangeli.it/Libro/Adolescenti-e-salute?Id=29304
Guerriero G. Il sonno è per noi ciò che la carica è per l’orologio. In: Camerota TC, editor. Adolescenti e salute: Aiutiamo i nostri figli a crescere sani. Pratici consigli di medici e specialisti. FrancoAngeli; 2024. p. 137–151. Available from:
Guerriero G, Bernhardsson S, Gunnarson S, Ioannou M, Liljedahl SI, Magnusson K, et al. Efficacy of transcutaneous vagus nerve stimulation as treatment for patients with depression. Göterborg: Västra Götalandsregionen, Sahlgrenska Universitetssjukhuset, HTA-centrum; 2020 p. 22. Report No.: Health Technology Assessment Report 2020:119
Ricerca
Recenti attività di ricerca
Principal Investigator in the tVNS-BPD study: Transcutaneous Vagus Nerve Stimulation (tVNS) for Borderline Personality Disorder (NCT05892900)
Principal Investigator in the study: A phase II, 8-week treatment, multicenter, randomized, doubleblind, placebo- controlled, parallel group trial to evaluate the efficacy, tolerability and safety of orally administered BI 1358894 in patients with Post-Traumatic Stress Syndrome (NCT05103657)
Principal Investigator in the study: A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12-week treatment period in patients with borderline personality disorder (C.I.: Marianne Goodman MD)
Investigator in the ODEN study: Addition of the dopamine stabilizer OSU6162 to SSRI medication for difficult-to- treat depression (P.I.: Jakob Näslund)
Investigator in the study: Biochemical and neuropsychological effects of acute administration of escitalopram in premenstrual dysphoric syndrome (P.I.: Johan Fredrik Emilsson; Sponsor: Prof. Elias Eriksson)
Utilizziamo i cookie per analizzare il traffico sul sito web e ottimizzare l'esperienza con il tuo sito. Accettando l'uso dei cookie da parte nostra, i tuoi dati saranno aggregati con i dati di tutti gli altri utenti.